It is worth noting that when a glycolytic cell line MIA Paca‐2, and a lipogenic cell line HPAC that expresses high levels of SCD and MUFAs, were treated with A37062, a SCD small molecule inhibitor, remarkable tumour growth suppression was observed only in the HPAC‐derived xenografted tumour.45 Although the antitumour effect of SCD suppression has been reported, milder therapeutic effect was observed in some cancers. Here, SCD is linked to neoplasm.